For the Inventor, By the Inventor

Enter assignee name

Societe Civile Bioprojet

USPTO Granted Patents = 20

Forward Citations = 471

Loading Chart...

Loading Chart...

40 inventors (with patents filed for the assignee):

Jean-Charles Schwartz (18 out of 62 patents)

Jeanne-Marie Lecomte (17 out of 55 patents)

Denis Danvy (10 out of 21 patents)

4. Lucette Duhamel (9 out of 28 patents)

5. Pierre Duhamel (9 out of 31 patents)

6. Claude Gros (8 out of 12 patents)

7. Jean-Christophe Plaquevent (8 out of 12 patents)

8. Jean-Michel Arrang (7 out of 13 patents)

9. Monique Garbarg (7 out of 12 patents)

10. Thierry Monteil (6 out of 12 patents)

11. Bruno Giros (4 out of 8 patents)

12. Holger Stark (4 out of 9 patents)

13. Walter Schunack (4 out of 17 patents)

14. Charon R Ganellin (4 out of 153 patents)

15. Ralph Lipp (3 out of 19 patents)

20 patents: Sort by Forward Citations

1. 7910605 - [object Object] (2011-03-22),

2. 7138413 - [object Object] (2006-11-21),

3. 6013829 - Process for the asymmetric synthesis of S-acyl derivatives of (2000-01-11),

4. 5985895 - 2-naphthamide derivatives and their therapeutic applications (1999-11-16),

5. 5846956 - Amino acids derivatives, the process for their preparation and their (1998-12-08),

6. 5786494 - Process for the synthesis of .alpha.-substituted acrylic acids and their (1998-07-28),

7. 5708171 - Imidazole derivatives for pharmaceutical use (1998-01-13),

8. 5670531 - Amino acid derivatives, the process for their preparation and their (1997-09-23),

9. 5646313 - Amino acid derivatives, processes for their preparation and their (1997-07-08),

10. 5599951 - Amino acid derivatives, the process for their preparation and their (1997-02-04),

11. 5559113 - Imidazole compounds and their therapeutic applications (1996-09-24),

12. 5342960 - Azomethines agonist compounds of the histamine H.sub.3 receptor for (1994-08-30),

13. 5331008 - Thioester enantiomeric compounds and their therapeutic uses (1994-07-19),

14. 5321039 - Method of inducing a histamine agonist action on H.sub.2 receptors (1994-06-14),

15. 5296509 - Thioester enantiomeric compounds and their therapeutic uses (1994-03-22),

Societe Civile Bioprojet is a pharmaceutical company headquartered in France. They specialize in the research, development, and commercialization of innovative medicines. With a dedication to improving patient care, Bioprojet focuses on therapeutic areas such as neurology, psychiatry, and inflammation. Their team of talented scientists and professionals work tirelessly to discover breakthrough treatments that address unmet medical needs. Visit their website for more information about their projects, products, and mission.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

20 Patents

#211 in Paris

#985 in France

#30,316 in the World

Societe Civile Bioprojet

Forward Citations = 471

40 inventors:

Jean-Charles Schwartz (18 out of 62 patents)

Jeanne-Marie Lecomte (17 out of 55 patents)

Denis Danvy (10 out of 21 patents)

4. Lucette Duhamel (9 out of 28 patents)

5. Pierre Duhamel (9 out of 31 patents)

Please report any incorrect information to support@idiyas.com

Loading…